아센디스 파마 A/S

SecurityASND / Ascendis Pharma A/S
InstitutionAperio Group, LLC
Latest Disclosed Ownership6,639 shares
Latest Disclosed Value $ 1,107,000
Aperio Group, LLC reports 14.57% decrease in ownership of ASND / Ascendis Pharma A/S

On February 5, 2021 - Aperio Group, LLC filed a 13F-HR form disclosing ownership of 6,639 shares of Ascendis Pharma A/S (US:ASND) valued at $1,107,252 USD as of December 31, 2020. The entity filed a previous 13F-HR on November 6, 2020 disclosing 7,771 shares of Ascendis Pharma A/S. This represents a change in shares of -14.57% during the quarter. The current value of the position is $1,397,178 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2021-02-05 2020-12-31 13F ASCENDIS PHARMA AS SPONSORED ADR 04351P101 6,639 -1,132 -14.57 1,107 -7.67 0.0033
2020-11-06 2020-09-30 13F ASCENDIS PHARMA AS SPONSORED ADR 04351P101 7,771 256 3.41 1,199 7.92 0.0040
2020-08-13 2020-06-30 13F ASCENDIS PHARMA A S SPONSORED ADR 04351P101 7,515 1,761 30.60 1,111 71.45 0.0041
2020-05-05 2020-03-31 13F ASCENDIS PHARMA A S SPONSORED ADR 04351P101 5,754 -698 -10.82 648 -27.84 0.0029
2020-02-13 2019-12-31 13F ASCENDIS PHARMA A S SPONSORED ADR 04351P101 6,452 1,505 30.42 898 88.66 0.0032
2019-11-06 2019-09-30 13F ASCENDIS PHARMA AS SPONSORED ADR 04351P101 4,947 365 7.97 476 -9.85 0.0019
2019-07-30 2019-06-30 13F ASCENDIS PHARMA AS SPONSORED ADR 04351P101 4,582 147 3.31 528 1.15 0.0022
2019-05-13 2019-03-31 13F ASCENDIS PHARMA A S SPONSORED ADR 04351P101 4,435 -1,712 -27.85 522 35.58 0.0023
2019-05-06 2018-12-31 13F/A-1 ASCENDIS PHARMA A S SPONSORED ADR 04351P101 6,147 -786 -11.34 385 -21.59 0.0019
2019-02-14 2018-12-31 13F ASCENDIS PHARMA A S SPONSORED ADR 04351P101 6,132 -801 384
2019-05-06 2018-09-30 13F/A-1 ASCENDIS PHARMA A S SPONSORED ADR 04351P101 6,933 431 6.63 491 13.39 0.0022
2018-10-17 2018-09-30 13F ASCENDIS PHARMA A S S COMMON 04351P101 6,933 431 491
2019-05-06 2018-06-30 13F/A-1 ASCENDIS PHARMA A S SPONSORED ADR 04351P101 6,502 -3,557 -35.36 433 -34.19 0.0021
2018-07-30 2018-06-30 13F ASCENDIS PHARMA A S S COMMON 04351P101 6,502 -3,557 433
2019-05-01 2018-03-31 13F/A-1 ASCENDIS PHARMA A S SPONSORED ADR 04351P101 10,059 3,191 46.46 658 139.27 0.0033
2018-05-08 2018-03-31 13F ASCENDIS PHARMA A S S COMMON 04351P101 10,059 3,191 658
2019-05-01 2017-12-31 13F/A-1 ASCENDIS PHARMA A S SPONSORED ADR 04351P101 6,868 209 3.14 275 14.11 0.0014
2018-02-02 2017-12-31 13F ASCENDIS PHARMA A S S COMMON 04351P101 6,868 209 275
2019-05-01 2017-09-30 13F/A-1 ASCENDIS PHARMA A S SPONSORED ADR 04351P101 6,659 6,659 241 0.0014
2017-10-25 2017-09-30 13F ASCENDIS PHARMA A S S COMMON 04351P101 6,659 6,659 241
2019-04-22 2017-06-30 13F/A-1 ASCENDIS PHARMA A S S COMMON 04351P101 0 -7,242 -100.00 0 -100.00
2019-04-22 2017-03-31 13F/A-1 ASCENDIS PHARMA A S SPONSORED ADR 04351P101 7,242 0 203 0.0014
2017-05-05 2017-03-31 13F ASCENDIS PHARMA A S S COMMON 04351P101 7,242 203
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.